LABinnovatorLABinnovator
COMPANYEVENTSPAST EVENTSPARTNERSCAREERSCONTACT

Patent Life Cycles

Mastering an IP Portfolio strategy to maximise
the value on your patents

Date: March 21, 2006
Venue:  Hotel D´Angleterre
City: Copenhagen, Denmark

In the Chair:

Dr. John Haurum
Chief Scientific Officer
SYMPHOGEN

Hear from your eminent Speaker Panel:

Dr. Wolfgang Ehrenstein
Chief Patent Counsel
BAYER HEALTHCARE AG

Lars Kellberg
Vice President Corporate Patents
NOVO NORDISK

Ola Flink
Managing Director
KAROLINSKA INNOVATIONS

Henrik Pedersen
Chief Scientific Officer
NUEVOLUTION

Kerstin Bergman
IP Director
BIOINVENT

Paul Inman
Solicitor
SIMMONS & SIMMONS

Donald O. Beers
Partner
ARNOLD & PORTER LLP (USA)

Event Summary:

The driving force behind innovation and growth lie in the organisation’s ability to successfully manage your IP portfolio. In the Life Sciences industry return on investment is being represented by the value generating ability of IP. Progressive biopharmaceuticals are able to avoid generic competition by building a new generation of products and services. This successfully extends the patent life cycles and your company’s opportunity to derive greater value from existing patent portfolios.

By mastering a patent life cycle management vision, your company will be able to successfully manage the patents from the start until the patents expire. Your business organisation is able to identify which patents add value in the future. A clear IP Portfolio strategy supports your company’s Patent Life Cycle Management vision to successfully protect your patents, avoids patent infringements and maximises the ROI on your innovations.

This international one day conference will bring your company the best strategies and tactics to protect your company’s most valuable assets, the patents, and successfully avoid generic competition. Our distinguished speaker panel will guide you through the steps necessary to maximise the value of your IP Portfolio now and in the future.

This conference will tackle key issues such as:

  • Examining the current status and future IPR trends in the global life sciences community
  • Developing a patent portfolio strategy to extend your patent life cycles
  • Maximising Freedom To Operate to extend your patent life cycles in a competitive business environment
  • Creating a new generation of drug products and services to add value to your existing patent portfolio
  • Defining a patent strategy to get the best out of your patent agents
  • Identifying technology partners to integrate in your R & D projects pipeline
  • Monitoring “reach-through” protection for antibodies to stay ahead of competition
  • Creating cross-disciplinary teams to choose the right patent strategies
  • Maximising the value of your IP Portfolio through strategic alliances
  • How to create a road map to extend your patent life cycles

Target audience and Job Titles:
Presidents, Chief Executive Officers, Chief IP Counsels, Chief Scientific Officers, Vice Presidents, Directors and Heads of:

  • Intellectual Property
  • Corporate Patents
  • Global Intellectual Property
  • Intellectual Property Rights
  • Corporate Patents and Trademarks
  • Patents - Biotechnology
  • IPR Strategy
  • Legal and Intellectual Property
  • Patents
  • Pharmaceutical Patents
  • Business Development
  • Patent Agents
  • European Patent Attorneys
  • Partners
  • Venture Capitalists
  • Consultants


LABinnovator